---
figid: PMC4671345__fcvm-02-00036-g003
figlink: /pmc/articles/PMC4671345/figure/F3/
number: F3
caption: LIF protects cardiac myocytes by both genomic and non-genomic means. Dimerization
  of gp130 and LIFR activates the associated JAK tyrosine kinases, which phosphorylate
  recruitment sites for STAT3 and STAT1 (YXXQ), and a scaffold protein SHP2 (YXXV)
  that is coupled to ERK1/2, ERK5, and phosphoinositide 3-kinase (PI3K)-Akt activation.
  STAT3 and the SHP2-based signaling pathways are linked to cellular protection and/or
  cell growth. JAK-mediated STAT3 phosphorylation on Y705 enhances its dimerization
  and DNA binding. Activated STAT3 induces expression of anti-apoptotic, anti-oxidative
  stress, and pro-angiogenic genes, and STAT3 S727 phosphorylation boosts gene transcription.
  In the nucleus, U-STAT3 may affect gene expression either as a transcription factor
  or by modulating chromatin structure. In parallel, STAT3 has protective actions
  on mitochondrial function. STAT3 optimizes mitochondrial respiration and limits
  ROS formation, thereby opposing mPTP opening and ensuring mitochondrial integrity.
  These non-genomic actions of STAT3 are enhanced by S727 phosphorylation. ERK1/2
  and Akt are components of the RISK pathway of cardiac protection that is evoked
  by pre- and postconditioning. ERK1/2 has protective effects on mitochondria via
  phosphorylation and inhibition of GSK3-α/β, which prevents mPTP opening. PI3K-Akt
  signaling also inhibits opening of mPTP via phosphorylation of GSK3-α/β or mitochondrial
  hexokinase II (HKII). See text for additional details. Adapted with permission from
  Zouein et al. ().
pmcid: PMC4671345
papertitle: 'Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic
  Stress: New Advancement and Unresolved Issues.'
reftext: Fouad A. Zouein, et al. Front Cardiovasc Med. 2015;2:36.
pmc_ranked_result_index: '168076'
pathway_score: 0.9575256
filename: fcvm-02-00036-g003.jpg
figtitle: LIF protects cardiac myocytes by both genomic and non-genomic means
year: '2015'
organisms: Homo sapiens
ndex: c5ff3d3b-dee4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4671345__fcvm-02-00036-g003.html
  '@type': Dataset
  description: LIF protects cardiac myocytes by both genomic and non-genomic means.
    Dimerization of gp130 and LIFR activates the associated JAK tyrosine kinases,
    which phosphorylate recruitment sites for STAT3 and STAT1 (YXXQ), and a scaffold
    protein SHP2 (YXXV) that is coupled to ERK1/2, ERK5, and phosphoinositide 3-kinase
    (PI3K)-Akt activation. STAT3 and the SHP2-based signaling pathways are linked
    to cellular protection and/or cell growth. JAK-mediated STAT3 phosphorylation
    on Y705 enhances its dimerization and DNA binding. Activated STAT3 induces expression
    of anti-apoptotic, anti-oxidative stress, and pro-angiogenic genes, and STAT3
    S727 phosphorylation boosts gene transcription. In the nucleus, U-STAT3 may affect
    gene expression either as a transcription factor or by modulating chromatin structure.
    In parallel, STAT3 has protective actions on mitochondrial function. STAT3 optimizes
    mitochondrial respiration and limits ROS formation, thereby opposing mPTP opening
    and ensuring mitochondrial integrity. These non-genomic actions of STAT3 are enhanced
    by S727 phosphorylation. ERK1/2 and Akt are components of the RISK pathway of
    cardiac protection that is evoked by pre- and postconditioning. ERK1/2 has protective
    effects on mitochondria via phosphorylation and inhibition of GSK3-α/β, which
    prevents mPTP opening. PI3K-Akt signaling also inhibits opening of mPTP via phosphorylation
    of GSK3-α/β or mitochondrial hexokinase II (HKII). See text for additional details.
    Adapted with permission from Zouein et al. ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK3
  - CDH2
  - CDH3
  - CDH5
  - CDH16
  - JAK1
  - JAK2
  - TYK2
  - MAPK1
  - LIF
  - AKT2
  - CDH15
  - AKT1
  - BCL2L1
  - PGF
  - VEGFA
  - VEGFB
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - CDH10
  - CDH11
  - CDH12
  - AKT3
  - SOS2
  - SOS1
  - EMD
  - CDH17
  - CDH18
  - CDH20
  - CDH19
  - CDH24
  - CDH13
  - MAPK3
  - CDH1
  - CDH4
  - GRB2
  - GSK3B
  - VEGFD
  - SART3
  - LIFR
  - HK2
  - HMOX1
  - CDH22
  - MCL1
  - VEGFC
  - STAT3
  - SOD2
  - RHOA
  - PTPN11
  - MPTP
genes:
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH3
  entrez: '1001'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH16
  entrez: '1014'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: LIF
  symbol: LIF
  source: hgnc_symbol
  hgnc_symbol: LIF
  entrez: '3976'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH15
  entrez: '1013'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Bcl-xl,
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: MCL-1,Bcl-xl,SOD2,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: MCL-1,Bcl-xl,SOD2,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: MCL-1,Bcl-xl,SOD2,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH6
  entrez: '1004'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH7
  entrez: '1005'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH8
  entrez: '1006'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH9
  entrez: '1007'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH10
  entrez: '1008'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH11
  entrez: '1009'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH12
  entrez: '1010'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: STA
  symbol: STA
  source: hgnc_alias_symbol
  hgnc_symbol: EMD
  entrez: '2010'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH17
  entrez: '1015'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH18
  entrez: '1016'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH20
  entrez: '28316'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH19
  entrez: '28513'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH24
  entrez: '64403'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH13
  entrez: '1012'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH4
  entrez: '1002'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: GSK3-B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MCL-1,Bcl-xl,SOD2,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: LIFR
  symbol: LIFR
  source: hgnc_symbol
  hgnc_symbol: LIFR
  entrez: '3977'
- word: HKII
  symbol: HK2
  source: hgnc_symbol
  hgnc_symbol: HK2
  entrez: '3099'
- word: HO-1
  symbol: HO-1
  source: hgnc_alias_symbol
  hgnc_symbol: HMOX1
  entrez: '3162'
- word: Cadherin
  symbol: Cadherin
  source: bioentities_symbol
  hgnc_symbol: CDH22
  entrez: '64405'
- word: MCL-1,
  symbol: Mcl-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: MCL-1,Bcl-xl,SOD2,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: MCL-1,Bcl-xl,SOD2,VEGF
  symbol: SOD2
  source: hgnc_symbol
  hgnc_symbol: SOD2
  entrez: '6648'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: SHP2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
chemicals:
- word: MPTP
  source: MESH
  identifier: D015632
diseases: []
figid_alias: PMC4671345__F3
redirect_from: /figures/PMC4671345__F3
figtype: Figure
---
